Re: Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.

Published on Apr 1, 2014in The Journal of Urology7.45
· DOI :10.1016/J.JURO.2014.01.074
Samir S. Taneja72
Estimated H-index: 72
Sources
Abstract
📖 Papers frequently viewed together
2016Oncology Times UK
2 Authors (Talha Shaikh, Eric M. Horwitz)
20117.04International Journal of Radiation Oncology Biology Physics
9 Authors (S.J. Feigenberg)
20107.04International Journal of Radiation Oncology Biology Physics
10 Authors (Hitoshi Ishikawa, ..., Takashi Nakano)
References1
Newest
May 1, 2006·The Journal of Urology7.45
#1Yair Lotan (UTSW: University of Texas Southwestern Medical Center)H-Index: 110
#2Jennifer Stanfield (UTSW: University of Texas Southwestern Medical Center)H-Index: 10
Last. Robert Timmerman (UTSW: University of Texas Southwestern Medical Center)H-Index: 70
view all 11 authors...
Purpose: SBRT is a new therapeutic paradigm using large dose per fraction treatments (aggressive hypofractionation). While SBRT has shown efficacy for treating patients with lung, liver and spine tumors, to our knowledge there have been no preclinical studies evaluating the efficacy of this treatment for prostate cancer. We investigated the dose-response characteristics of SBRT for treating human prostate cancer in a nude mouse model.Materials and Methods: Nude mice were injected subcutaneously ...
Source
1
Cited By0
Newest
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.